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Dear Editor,
We read the recent article "Influence of obstructive sleep
apnea on serum butyrylcholinesterase activity and ische-
mia-modified albumin levels" by Liu-Xue Yang et al. with
great interest (1). It is interesting that the ischemia-modified
albumin (IMA) level was significantly associated with
obstructive sleep apnea and that the IMA level was a more
sensitive indicator of obstructive sleep apnea than butyr-
ylcholinesterase activity. We appreciate the authors’ well-
designed study and encouraging results, which will act as a
guide for additional basic and clinical research on OSA. To
our knowledge, it is the first study to examine IMA in
relation to OSA. However, we still have some concerns
about this study.
IMA, which is produced by ischemia stresses (e.g.,
hypoxia, acidosis, and free radical injury), increases within
minutes after the onset of ischemia, remains elevated for 6–
12 h, and returns to normal within 24 h (2). The attenuation
of IMA often indicates an acute ischemic event, such as
acute coronary syndrome, a pulmonary embolism, or acute
ischemic stroke (3-5).
In this study, blood samples were drawn from OSA
patients after an overnight fast so that the peak IMA
concentration would be properly timed to yield positive
results. However, if extra IMA values were collected using
dynamic observation with overnight polysomnography in
the sleep unit, especially when the patients appeared to
experience sleep apnea or a decrease in SaO2, the ischemia
and oxidative stress mechanisms of OSA could be further
clarified. We hypothesize that there is dynamic ischemic
damage in OSA patients: mild ischemia and anoxia appear
during the daytime, and while the patients sleep, apnea
occurs and leads to even more serious ischemia and anoxia.
In addition, a minor problem may exist in this study. It is
well known that OSA often leads to ischemic diseases,
increases the incidence of coronary artery disease (CAD),
and raises the risk of cardiovascular diseases (CVEs) (6,7). In
this study, ischemic diseases, even stable CAD (which is
associated with an elevated IMA level according to our
research) (8), were not considered among the baseline
characteristics of the two groups. This minor carelessness
may have played a role in the positive results of the study.
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